NXL-008

N/A

Report date: 2025/01/26 16:38:57

Base Information

Drug NameNXL-008
Drug Alias NameAAV-based gene therapy (NeuExcell Therapeutics)adeno-associated viral vector-based gene therapy (NeuExcell Therapeutics)NXL-008
ClassificationBiologics
Mechanisms of ActionNeuroprotectants
TargetsUpdating
Therapy Area/IndicationsNerve Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNeuExcell Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesNeuExcell Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsNerve Degeneration
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A